Educational information, not medical advice — ask your doctor or midwife.
Kacip Fatimah (Labisia pumila) is a low-growing herb native to the tropical rainforests of Malaysia, Thailand, and Borneo. It has been used for centuries in traditional Malay medicine, particularly by women during pregnancy, childbirth, and menopause. The plant is so deeply woven into Malay women's health culture that it is sometimes called the 'women's herb' of Southeast Asia.
Kacip Fatimah contains plant-based compounds that are thought to interact with estrogen receptors in the body, which may help support hormonal balance — particularly during perimenopause and menopause when estrogen levels decline. These phytoestrogens are believed to bind to estrogen receptors, though how this compares in effect or safety to other estrogenic approaches is not yet well established by clinical research. The plant is also thought to have antioxidant and anti-inflammatory properties, which may contribute to its traditional reputation for supporting reproductive and metabolic health.
Standardized capsule and extract forms offer the most consistent dosing and are preferred for reliable results. Traditional decoction (boiling the roots or leaves) remains widely used in Malaysia. Look for products standardized to total flavonoid or saponin content for best results.
Used for hundreds of years in Malaysian and Indonesian traditional medicine, Kacip Fatimah was traditionally given to women after childbirth to help tighten the uterus, restore energy, and support postpartum recovery. It was also used to ease labor, regulate menstruation, and maintain women's vitality into older age. Malaysian herbalists have long considered it among the most important women's herbs in the Malay pharmacopeia.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.